| scholarly article | Q13442814 |
| P50 | author | Christian Torp-Pedersen | Q33310590 |
| Lars Køber | Q33310611 | ||
| Helena Dominguez | Q42145479 | ||
| Christian Rask-Madsen | Q88203686 | ||
| Nikolaj Ihlemann | Q114294554 | ||
| P2093 | author name string | Thomas Hermann | |
| P433 | issue | 15 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 1815-1821 | |
| P577 | publication date | 2003-10-06 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Tumor necrosis factor-alpha inhibits insulin's stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans | |
| P478 | volume | 108 |
| Q52651135 | A novel biomarker in patients with knee osteoarthritis: adropin. |
| Q53150255 | A possible connection between tumor necrosis factor alpha and adropin levels in polycystic ovary syndrome. |
| Q36844673 | AGE/RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice |
| Q34002877 | Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells |
| Q36896425 | Adipokines and hepatic insulin resistance |
| Q36112058 | An immune origin of type 2 diabetes? |
| Q37035654 | An integrated view of insulin resistance and endothelial dysfunction |
| Q45016980 | C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. |
| Q37980497 | Cardiovascular metabolic syndrome: mediators involved in the pathophysiology from obesity to coronary heart disease |
| Q53645973 | Characterization of the cytokine expression profiles of the aorta and liver of young tumor necrosis factor alpha mutant mice. |
| Q37580907 | Contribution of insulin resistance to vascular dysfunction. |
| Q34427072 | Coronary microvascular dysfunction in diabetes mellitus: A review |
| Q35373283 | Crosstalk between intestinal microbiota, adipose tissue and skeletal muscle as an early event in systemic low-grade inflammation and the development of obesity and diabetes |
| Q36038059 | Cytokines and vascular reactivity in resistance arteries |
| Q37292552 | Derangements in blood glucose following initial resuscitation from in-hospital cardiac arrest: a report from the national registry of cardiopulmonary resuscitation |
| Q39133016 | Differential inhibition by hyperglycaemia of shear stress- but not acetylcholine-mediated dilatation in the iliac artery of the anaesthetized pig. |
| Q37402790 | Does Glucagon-like Peptide-1 Ameliorate Oxidative Stress in Diabetes? Evidence Based on Experimental and Clinical Studies. |
| Q36629691 | Effects of GLP-1 on forearm vasodilator function and glucose disposal during hyperinsulinemia in the metabolic syndrome |
| Q38082465 | Endothelial dysfunction in (pre)diabetes: characteristics, causative mechanisms and pathogenic role in type 2 diabetes |
| Q37639902 | Endothelium and its alterations in cardiovascular diseases: life style intervention |
| Q46207322 | Evaluation of tumor necrosis factor alpha serum level in obese and lean women with clomiphene citrate-resistant polycystic ovary disease |
| Q42869230 | Generalized impairment of vasodilator reactivity during hyperinsulinemia in patients with obesity-related metabolic syndrome |
| Q38236166 | Glycemic variability and acute ischemic stroke: the missing link? |
| Q89885190 | Gut microbiota and obesity: Impact of antibiotics and prebiotics and potential for musculoskeletal health |
| Q35638692 | High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors |
| Q27021665 | Human obesity and endothelium-dependent responsiveness |
| Q37692824 | Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management |
| Q37772395 | Hyperglycemia in aneurysmal subarachnoid hemorrhage: a potentially modifiable risk factor for poor outcome |
| Q51288126 | Hypoglycemic and anti-inflammatory effects of seabuckthorn seed protein in diabetic ICR mice. |
| Q39368775 | Inflammation mediates the association between visceral adiposity and obstructive sleep apnea in adolescents |
| Q37371379 | Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms |
| Q30277770 | Insulin Enhances Endothelial Function Throughout the Arterial Tree in Healthy But Not Metabolic Syndrome Subjects |
| Q36458543 | Insulin resistance--a common link between type 2 diabetes and cardiovascular disease |
| Q36838847 | Insulin signalling mechanisms for triacylglycerol storage |
| Q37428743 | Management of cardiovascular disease risk in chronic inflammatory disorders |
| Q37250713 | Maturation-induces endothelial dysfunction via vascular inflammation in diabetic mice |
| Q36688361 | Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes |
| Q36766940 | Mediterranean diet, endothelial function and vascular inflammatory markers |
| Q53693245 | Metabolic syndrome in systemic lupus erythematosus patients : Relationship to disease activity and neuropsychiatric lupus. |
| Q34635250 | Metabolic syndrome, chronic kidney, and cardiovascular diseases: role of adipokines. |
| Q37857912 | Obesity, blood vessels and metabolic syndrome |
| Q37375332 | Oxidative stress in diabetes: implications for vascular and other complications |
| Q40507825 | Phosphorylation of threonine 290 in the activation loop of Tpl2/Cot is necessary but not sufficient for kinase activity |
| Q41608422 | Prevalence of metabolic syndrome in a cohort of systemic lupus erythematosus patients from Northeastern Brazil: association with disease activity, nephritis, smoking, and age. |
| Q46374459 | Prolonged local forearm hyperinsulinemia induces sustained enhancement of nitric oxide-dependent vasodilation in healthy subjects |
| Q30424339 | Role of the immune system in hypertension: modulation by dietary antioxidants |
| Q89314644 | Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases |
| Q40186727 | The effect of tumour necrosis factor-α and insulin on equine digital blood vessel function in vitro |
| Q36216822 | The heart in obesity-hypertension |
| Q34769627 | The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats |
| Q37207043 | The role of inflammatory cytokines in endothelial dysfunction |
| Q36673550 | The vascular endothelium in diabetes--a therapeutic target? |
| Q38034926 | Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease |
| Q47886547 | Tumour necrosis factor-alpha infusion produced insulin resistance but no change in the incretin effect in healthy volunteers |
| Q41096079 | Upregulation of TNF-alpha and Receptors Contribute to Endothelial Dysfunction in Zucker Diabetic Rats |
| Q35106315 | Vascular biology of metabolic syndrome |
| Q35911588 | What are the effects of peroxisome proliferator-activated receptor agonists on adiponectin, tumor necrosis factor-alpha, and other cytokines in insulin resistance? |
Search more.